Holen Sie sich die Stockscreener-App
3.14
3.63%
0.11
Handel nachbörslich:
3.17
0.03
+0.96%
Schlusskurs vom Vortag:
$3.03
Offen:
$3.03
24-Stunden-Volumen:
8,575
Relative Volume:
0.07
Marktkapitalisierung:
$3.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.27M
KGV:
-0.1466
EPS:
-21.4132
Netto-Cashflow:
$-9.40M
1W Leistung:
+20.77%
1M Leistung:
-16.49%
6M Leistung:
-56.99%
1J Leistung:
-71.45%
1-Tages-Spanne:
$3.03
$3.14
1-Wochen-Bereich:
$2.53
$3.14
52-Wochen-Spanne:
$2.36
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Firmenname
Dermata Therapeutics Inc
Sektor
Branche
Telefon
(858)-223-0882
Adresse
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Vergleichen Sie DRMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
3.14 | 3.11M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Dermata Therapeutics Inc Aktie (DRMA) Neueste Nachrichten
Returns Recap: Will Dermata Therapeutics Inc. stock see insider buyingWeekly Trade Review & Detailed Earnings Play Strategies - moha.gov.vn
Is Dermata Therapeutics Inc. stock a contrarian buyJuly 2025 Reactions & Entry Point Confirmation Signals - moha.gov.vn
Dermata Therapeutics Inc files for mixed shelf of up to $100 million - MarketScreener
Dermata Therapeutics, Inc.Warrant (NQ: DRMAW - Markets Financial Content
What momentum indicators show for Dermata Therapeutics Inc. Equity Warrant stockStock Surge & Real-Time Market Sentiment Alerts - newser.com
Can Dermata Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - newser.com
Dermata Therapeutics Ends License Agreement with Villani - MSN
Can Dermata Therapeutics Inc. Equity Warrant stock sustain market leadershipTrend Reversal & Trade Opportunity Analysis - newser.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Statistical indicators supporting Dermata Therapeutics Inc.’s strengthEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
Is Dermata Therapeutics Inc. Equity Warrant stock a safe investment in uncertain marketsWeekly Trading Summary & Weekly High Potential Stock Alerts - newser.com
Is Dermata Therapeutics Inc. Equity Warrant stock vulnerable to regulatory risksJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Why Dermata Therapeutics Inc. stock could see breakout soonWeekly Investment Summary & Stock Market Timing Techniques - newser.com
Can Dermata Therapeutics Inc. stock sustain market leadershipJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - newser.com
How to manage a losing position in Dermata Therapeutics Inc.July 2025 Market Mood & Weekly Setup with High ROI Potential - newser.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Will Dermata Therapeutics Inc. stock benefit from green energy trendsQuarterly Profit Review & Low Drawdown Investment Ideas - newser.com
How to use Fibonacci retracement on Dermata Therapeutics Inc.Dollar Strength & Real-Time Buy Signal Alerts - newser.com
Can Dermata Therapeutics Inc. Equity Warrant stock resist market sell offsJuly 2025 Price Swings & Breakout Confirmation Alerts - newser.com
Is Dermata Therapeutics Inc. Equity Warrant building a consolidation base2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Has Dermata Therapeutics Inc. formed a bullish divergenceMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
Dermata Therapeutics Incon Nov 17, Termina - 富途牛牛
Visualizing Dermata Therapeutics Inc. stock with heatmapsShare Buyback & Step-by-Step Trade Execution Guides - newser.com
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - Chronicle-Tribune
Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):